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Available online 9 August 2011Abstract Hair follicle harbors a rich stem cell pool with mesenchymal lineage differentiation potential. Although previous
studies with rodent cells demonstrated that hair follicle sheath and papilla cells possess multi-lineage differentiation potential,
human hair follicle derived mesenchymal stem cells (hHF-MSCs) have not been characterized in detail in terms of their
multipotency. In addition, it is not clear whether these cells are true stem cells that can differentiate along multiple lineages or
whether they represent a collection of progenitor cells with restricted differentiation potential. Here we report that hHF-MSCs
are highly proliferative cells that can be maintained in culture for ~45 population doublings before they start to show signs of
cellular senescence. Under appropriate culture conditions, hHF-MSCs differentiated along the myogenic, osteogenic,
adipogenic and chondrogenic lineages, as demonstrated by kinetic gene expression profiling and functional assays.
Interestingly, the differentiation potential decreased with time in culture in a lineage-specific manner. Specifically,
myogenesis and chondrogenesis showed a moderate decrease over time; osteogenesis was maximum at intermediate passages
and adipogenesis was highly sensitive to long-term culture and was diminished at late passages. Finally, hHF-MSCs were clonally
multipotent as the majority of hHF-MSCs clones (73%) demonstrated bi- or tri-lineage differentiation potential. These results
suggest that hHF-MSCs may present as an alternative source of easily accessible, autologous stem cells for tissue engineering
and regenerative medicine.
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75Hair follicle derived MSCs are clonally multipotentIntroduction
Skin is the largest organ and plays a key role inmaintaining the
body's homeostasis. One of the skin appendages, the hair
follicle, is an easily accessible mini-organ with a number of
important functions such as protection against cold, injuries
and pathogens (Paus and Cotsarelis, 1999). The hair follicle
undergoes numerous cycles of growth and retraction through-
out the adult life, prompting scientists to hypothesize that this
mini-organ might be a rich source of stem cells. However, the
anatomic location where stem cells resided remained elusive
until 1990 when Cotsarelis et al. first demonstrated that label-
retaining cells resided in the bulge of the hair follicle
(Cotsarelis et al., 1990), a finding that was later verified
using transgenic mice (Morris et al., 2004; Tumbar et al.,
2004). During the hair growth phase (anagen) bulge stem cells
are activated and migrate to the base of the hair follicle, the
bulb region, where they proliferate and differentiate to
regenerate the inner and outer root sheath, matrix and hair
shaft (Alonso and Fuchs, 2006). In addition to hair growth,
bulge derived stem cells also contribute to epidermal
regeneration in response to skin injury (Taylor et al., 2000).
Interestingly, bugle stem cells exhibited robust multipotency
as they could differentiate to multiple cell types including
neurons, glia, keratinocytes and melanocytes (Amoh et al.,
2005; Yu et al., 2010).
Although the bulge derives from the ectoderm, a cell
population ofmesodermal origin is also present within the hair
follicle tissue (Schneider et al., 2009). Mesodermal derived
cells are located in the dermal papilla and dermal sheath and
appear to regulate hair follicle development and cycling
through cross-talk with the epithelium (Schneider et al.,
2009). Hair follicle dermal papilla/sheath cells promote hair
restoration upon transplantation (Jahoda et al., 1984;
McElwee et al., 2003) and have been reported to be
immunoprivileged (Reynolds et al., 1999). Previous studies
showed that rodent dermal papilla/sheath cells have broad
differentiation potential, similar to bone marrow derived
mesenchymal stem cells (Jahoda et al., 2003; Hoogduijn et
al., 2006). Notably, transplantation experiments showed that
cells derived from the dermal papilla/sheath of mouse hair
follicles reconstituted multiple lineages of the hematopoietic
system of lethally irradiated mice, suggesting that these
mesenchymal cells have very broad differentiation potential
(Lako et al., 2002). Recently our group demonstrated that
dermal papilla/sheath cells from human hair follicles exhib-
ited mesenchymal stem cell (MSC) immunophenotype and
differentiated to all mesenchymal lineages and therefore,
they were termed human hair follicle derived mesenchymal
stem cells (hHF-MSCs) (Liu et al., 2010). In addition, using a
smooth muscle α-actin promoter we derived functional
smooth muscle cells (SMC) from human and ovine HF-MSCs,
which were used to engineer small-diameter vascular
constructs exhibiting robust contractility in response to
vasoactive agonists (Liu et al., 2008; Peng et al., 2011).
In contrast to MSCs from bone marrow or adipose tissue,
human hair follicle derived MSCs have not been characterized
in terms of their multipotency. Specifically, it is not known
whether hHF-MSCs are clonally multipotent or whether they
represent a collection of progenitor cells with restricted
differentiation potential. In addition, it is not known how the
hHF-MSCs differentiation potential changes over time inculture. Here we addressed these questions using gene
expression analysis, functional assays and clonal analysis and
found that hHF-MSCs are highly proliferative and multipotent
stem cells with great potential for tissue regeneration and cell
therapies.Results
hHF-MSCs maintain their proliferative capacity over
long culture period
hHF-MSCs were isolated from human scalp hair follicles and
expanded in DMEM supplemented with 10% FBS and 1 ng/mL
bFGF. The cells exhibited small, elongated, fibroblast-like
morphology (Figure 1A), had normal karyotype (Figure 1B) and
expressed surface markers characteristic of mesenchymal
stemcells (Figure S1). To examine their proliferation capacity,
hHF-MSCs were seeded at 3000 cells/cm2 and passaged every
fourth day. In each passage the total cells were counted and
the number of divisions was calculated. The number of
population doublings remained relatively constant for 11–12
passages (approximately 2.5 to 3.5 divisions per passage) and
declined sharply thereafter, reaching less than one doubling
over a 4-day periodby passage 14 (Figure 1C). At the same time
the cells appeared larger and flatter possibly as a result of
cellular senescence. Indeed, staining for the senescence
associated β-galactosidase (SA β-Gal) revealed that the
fraction of SA β-gal positive cells increased over time in
culture (Figures 1D, E). While, only a small fraction of cells
(b5%) appeared SA β-Gal positive on passages 5 and 8, this
number increased to 91±7% by passage 14 (n=3) (Figure 1E).Kinetics of gene expression during differentiation of
hHF-MSCs
Next we evaluated the multi-lineage differentiation potential
of hHF-MSCs toward myogenic, osteogenic, adipogenic and
chondrogenic lineages using quantitative real time PCR.
Myogenic differentiation was induced by treatment with
2 ng/mL TGF-β1 (Liu et al., 2008; Kinner et al., 2002; Narita
et al., 2008) and total mRNA was isolated daily for a period of
6 days. The expression level of three smooth muscle specific
genes, smooth muscle α-actin (α-SMA), SM22 and myocardin
(Owens, 1995; Wang et al., 2003), was measured as a function
of time. As illustrated in Figure 2A all three genes were
significantly up-regulated upon TGF-β1 treatment as
compared to non-treated cells (pb0.05). More specifically,
α-SMA exhibited the highest expression on the first 2 days of
treatment (day 2: 10±1.8 fold, n=3, pb0.05 as compared to
day 0) and decreased thereafter to 4.4±0.78 fold on day 6
(n=3, pb0.05 as compared to day 2). Similar toα-SMA the level
of SM22 increased on day 2 (day 2: 11.2±3.7 fold, n=3, pb0.01
as compared to day 0) and decreased significantly on day 6 (day
6: 5.9±0.5 fold, n=3, pb0.05 as compared to day 2).
Interestingly, expression of myocardin increased dramatically
and showed a periodic kinetic pattern, demonstrating maxima
on days 3 and 5 (day 3: 731±172 fold, n=3; and day 5: 932±204,
n=3) andminima on days 2, 4 and 6 (day 2: 10.4+3.8 fold, n=3;
day 4: 220±11, n=3; and day 6: 495±181, n=3). It is worth
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Figure 1 hHF-MSCs exhibited high proliferation potential. (A) hHF-MSCs morphology. (B) Karyotype analysis of hHF-MSCs shows no
chromosomal abnormality. (C) hHF-MSCs were plated at 3000 cells/cm2 and passaged every 4 days. The number of cells was counted at
each passage and the number of cell divisionswas calculated for 14 passages (n=3). (D) Senescence associatedβ-Galactosidase (SA-β-Gal)
staining of hHF-MSCs at passages 5 (P5) and 14 (P14). (E) Quantitative analysis of SA-β-Gal positive cells as a function of the number of
passages (n=3). Bars=400 μm.
76 V.K. Bajpai et al.transient increase in myocardin expression concomitant with
TGF-β1 stimulation.
During adipogenic induction hHF-MSCs rounded up and at
later stages, started accumulating oil droplets signifying
terminal adipogenic differentiation. To monitor the
transcriptional profile of adipogenesis, RNA was isolated
at days 2, 4, 8, 14, 16 and 21 and the relative expression
levels of PPARγ, lipoprotein lipase and leptin were
measured by RT-PCR (Figure 2B). Statistical analysis
demonstrated significant upregulation of lineage specific
markers during adipogenesis (pb0.001). More specifically,
the regulatory transcription factor PPARγ increased con-
tinuously reaching expression levels of 7.2±0.8 fold on day
21 (n=3, pb0.001 as compared to day 0). Early marker,
lipoprotein lipase (Ailhaud, 1996) and late marker, leptin
(MacDougald et al., 1995) are secreted by adipocytes and
their expression is believed to be highly up-regulated
during adipogenesis (Gregoire et al., 1998). Both markers
showed a sharp increase after day 8 reaching the highest
levels of expression on day 21. In particular, the level of
leptin increased to 231±26 fold on day 21 and lipoprotein
lipase increased dramatically to 45,600±2114 fold as
compared to non-differentiated cells (n=3).hHF-MSCs cultured under osteogenic conditions increased
the expression of osteogenic genes such as RUNX-2, alkaline
phosphatase, and osteonectin (pb0.001) (Figure 2C). RUNX-2, a
key transcription factor for osteogenesis (Komori et al., 1997),
showed a steady expression throughout the differentiation
period reaching 3.9±0.8 fold on day 21 (n=3, pb0.05 as
compared to day 0). Osteonectin increased to a similar level
reaching maximum on day 8 (3.09±0.18 fold, n=3, pb0.05 as
compared to day 21). On the other hand, alkaline phosphatase
was highly induced throughout the differentiation period,
reaching maximum level on day 21 (301±70 fold, n=3, pb0.05
as compared to day 0).
Chondrogenic differentiation conditions induced expression
of three lineage specific genes, namely SOX-9, aggrecan and
collagen type X (pb0.001) (Figure 2D). In 2D cultures,
mesenchymal condensation occurred rapidly and became
apparent under the microscope by day 4. The transcription
factor SOX-9 that regulates chondrogenic differentiation
(Akiyama et al., 2002) was up-regulated early on and was
expressed at 159±31 fold on day 21 (n=3, pb0.05 as compared
to day 0). Aggrecan, amaturemarker of chondrogenesis (Zuscik
et al., 2008), was expressed at later stages of differentiation
reachingmaximum levels on day 16 (day 16: 10,171±2166 fold,
Figure 2 Transcriptional profile of lineage specific genes during differentiation. RT-PCR for the indicated genes in (A) myogenic;
(B) adipogenic; (C) osteogenic; and (D) chondrogenic lineages. The ribosomal gene RPL32 served as a reference gene. The data at each
time was normalized to that of undifferentiated cells (day 0) and plotted as mean±SD (n=3).
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thereafter (day 21: 8314±3454 fold, n=3, p>0.05 as compared
to day 16). Another chondrogenic marker, collagen type X also
increased upon chondrogenic induction (day 4: 23.4±4 fold,
n=3, pb0.05 as compared to day 0) and continued to increase
at later times (day 21: 60.1±20.3 fold, n=3, pb0.05 as
compared to day 4).Long-term in vitro expansion reduces the
differentiation potential of hHF-MSCs
Next we examined the effect of prolonged in vitro expansion
on the differentiation potential of hHF-MSCs. To this end, hHF-
MSCs were differentiated toward the osteogenic, adipogenic,chondrogenic or myogenic lineage at different passages
(passages 5, 8 and 11). The degree of differentiation was
assessed by lineage specific functional assays, namely Oil Red
O stain for adipogenesis, Von Kossa stain for osteogenesis,
Alcian Blue stain for chondrogenesis and α-SMA expression and
fibrin gel compaction for myogenesis.
As shown in Figure 3A hHF-MSCs that were differentiated to
smooth muscle cells (SMC) showed increased expression of
α-SMA, calponin and myosin heavy chain (MHC). hHF-MSCs that
were cultured in proliferation medium (PM) showed low levels
and diffuse staining of all three proteins. On the other hand in
differentiation medium (DM), all three proteins showed robust
expression and filamentous organization that is characteristic
of SMCphenotype. Todetermine theeffect of in vitro expansion
on myogenesis we performed two independent experiments.
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different passages using flow cytometry. As shown in Figure 3B
the fraction of α-SMA positive cells was 8–15 times higher in
myogenic DM as compared to PM for all passages. Interestingly,
the fraction of α-SMA+ cells was higher at passage 8 (P5: 67.5±
2% vs. P8: 83.7±3%; n=3, pb0.001) and decreased at passage
11 (P11: 51.4±3.2; n=3, pb0.001 as compared to P8). Second,
since the quintessential attribute of SMC is their ability to
generate force,wealsomeasured fibrin gel compactionbyhHF-
MSCs as a function of time in culture. As shown in Figure 3C,
prolonged in vitro culture had a small but statistically
significant effect on gel compaction. After 96 h, P5 hHF-MSCs
decreased the area of fibrin hydrogels to 7.7±1% of the initial
area compared to P11 hHF-MSCs which compacted the
hydrogels to 19±2% of the initial area (n=3; pb0.05) suggesting
that hHF-MSCs maintain their ability to contract even at late
passages (Figure 3C). Taken together these results suggest that
myogenic differentiation potential and contraction of hHF-
MSCs appear to be largely unaffected by in-vitro expansion up
to passage 11.
Osteogenesis showed similar trend with myogenesis as
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was found to be the highest for P8 cells and then decreased
significantly by P11 (Figure 4A). Von Kossa positive area
(quantified using ImageJ) showed that 85±7% area was
mineralized in P8 hHF-MSCs compared to 36 ± 7%
(p=1.8×10−7) and 17±4% (p=1.3×10−8) in P5 and P11 hHF-
MSCs, respectively (Figure 4A). Chondrogenesis was examined
through Alcian Blue staining that positively stains sulfated
glycosaminoglycans (GAG) (blue color). Measurements of the
area that was stained blue revealed that chondrogenic
potential decreased gradually over time, reaching approxi-
mately half of its initial value by P11 (42±6% blue area)
(Figure 4B). GAG deposition was highest in P5 hHF-MSCs (74±
7% blue area) compared to P8 hHF-MSCs (61±11% blue area,
pb0.05) (Figure 4B). In contrast, adipogenesis showed
dramatic reduction between P5 and P11 as demonstrated by
Oil Red O staining and oil droplet quantitation (15±3% oil
droplet area in P5 compared to 1±0.6% in P11, p=1.6×10−6)
(Figure 4C). These results demonstrate that the adipogenic
and osteogenic differentiation potential of hHF-MSCs were
more sensitive to prolonged in vitro culture compared to
myogenic and chondrogenic potential.C
in MHC
entiation of hHF-MSCs. (A) Immunocytochemistry of P8 hHF-MSCs
11) hHF-MSCs were induced to differentiate and the extent of
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Figure 4 Effect of long-term in vitro expansion on hHF-MSCs differentiation potential. At the indicated passage (P5, P8, P11) hHF-MSCs
were induced to differentiate and the extent of differentiationwas assessedbyVonKossa stain for osteogenic lineage (A), Alcian Blue stain for
chondrogenic lineage (B) and Oil Red O stain for adipogenic lineage (C). Multiple pictures were acquired from each Alcian Blue or von Kossa
stained sample and used to generatemosaic images. The stained area in each imagewas quantified using ImageJ. (DM: Differentiation Media,
PM: Proliferation Media). (A, B) Bar=2 mm; (C) Bar=200 μm. * Denotes pb0.05.
79Hair follicle derived MSCs are clonally multipotentClonal populations of hHF-MSCs exhibitedmultipotent
differentiation potential
Although these results demonstrated the multi-lineage
differentiation potential of hHF-MSCs, it was not clear
whether hHF-MSCs were true multipotent stem cells or a
collection of various progenitors each with unipotent
differentiation ability. To address this issue, we plated
hHF-MSCs as single cells in each well of five 96-well plates.
Wells containing more than one cell were discarded, whereas
single cells were allowed to expand. Thirty seven clones
were selected and evaluated for adipogenic, osteogenic and
chondrogenic differentiation potential. Since the vast
majority of hHF-MSCs could differentiate to SMCs (>80% of
P8 cells were α-SMA+) the clones were not examined for
myogenic potential. These results are summarized in Table 1
and representative images for tri-potent, bi-potent and uni-
potent clones are shown in Figure 5.
Interestingly, 13 out of 37 clones (~35%) demonstrated
tri-lineage differentiation potential and 14 out of 37 clones
(~38%) exhibited bi-potent differentiation to chondrogenic
and osteogenic lineages. Seven clones (~19%) showed
unipotent characteristics, whereas only three clones (~8%)
failed to differentiate to any of the three lineages. It is worth
noting that these experiments were carried out with passage4 cells that were expanded from single cells, and therefore,
underwent approximately 20 population doublings (corre-
sponding to passages 10–11) before the differentiation
potential was evaluated. Therefore, our results demonstrate
that a significant fraction of hHF-MSCs retainedmultipotency
even after prolonged culture times.Discussion
The hair follicle is an easily accessible organ that covers large
areas of the skin and harbors distinct populations of stem cells,
probably owing to its diverse developmental (ecto-mesodermal)
origin (Cotsarelis et al., 1990; Morris et al., 2004; Tumbar et al.,
2004; Jahoda et al., 2003; Yu et al., 2006). Previous studies
showed that cells from the dermal papilla/sheath of rodent
(Jahoda et al., 2003; Hoogduijn et al., 2006) and human hair
follicles (Liu et al., 2010; Liu et al., 2008) displayed
characteristics of mesenchymal stem cells but human HF-MSCs
have not been investigated in detail. Here we addressed two
questions: (i) how does in vitro culture affect the proliferation
andmulti-lineage differentiation potential of hHF-MSCs; and (ii)
are hHF-MSCs clonallymultipotent?We found that hHF-MSCs are
highly proliferative cells that can be maintained in culture for
~45 population doublings before they begin to show signs of
Table 1 Clonal analysis of hHF-MSCs differentiation potential. hHF-MSCs clones were generated from single cells in 96-well
plates using the limited dilution method. HF-MSCs clones were differentiated toward adipogenic, osteogenic and chondrogenic
lineages and their differentiation potential was assessed by Oil red O, Von Kossa and Alcian Blue staining, respectively.
Clonal potential Number of 
clones
%  in total clone 
number
3 lineages 13 35.14
2 lineages 14 37.84
1 lineage 7 18.92
No differentiation 3 8.11
Total 37
Adipogenic Chondrogenic Osteogenic # of 
clones
















80 V.K. Bajpai et al.cellular senescence. Gene expression profiling and functional
assays demonstrated that hHF-MSCs can differentiate to
myogenic, osteogenic, adipogenic and chondrogenic lineages.
Interestingly, although adipogenesis decreased significantly
over time in culture, myogenesis and chondrogenesis decreased
to amuch lesser extent even after 11 passages,while osteogenic
capacity was highest at intermediate passages. In addition, the
majority of hHF-MSCswereclonallymultipotent, suggesting that
they may present an alternative source of easily accessible,
autologous stem cells for tissue engineering and regenerative
medicine.
hHF-MSCs displayed high proliferation potential over
several passages. Based on the average number of population
doublings per passage (2.5–3.5), it was estimated that hHF-
MSCs underwent ~36 population doublings during the first 12
passages. Addition of 8–10 population doublings that took
place during the initial isolation and expansion phase brings
the total number between 44and 46population doublings. This
compares favorably with previous reports estimating 13–25
population doublings for human BM-MSCs (Wagner et al.,
2008), although admittedly more accurate comparison would
require that both hHF-MSCs and BM-MSCs be isolated from the
same donors and account for sex and age differences.
Regardless, during the first 2 weeks of cell isolation a single
scalp hair follicle can give rise to approximately 5×104 MSCs,
which then undergo ~36 additional population doublings
yielding ~1015 cells. Given that the density of hair follicles in
the scalp is over 200 follicles/cm2 (Barman et al., 1965) and
thatmost of themare in the anagen phase for prolonged times,
the potential of hHF-MSCs as a stem cell source for
regenerative medicine is very promising.
As expected, there was a significant upregulation of early
and late lineage-specific genes during hHF-MSCs differentiation.
Smooth muscle specific genes such as α-SMA, SM22 and
myocardin were upregulated significantly during myogenic
induction. Interestingly, expression of myocardin displayed a
periodic kinetic pattern with maxima on days 3 and 5 following
the change of culture medium on days 2 and 4. This kinetic
pattern suggested thatmyocardinwas highly induced by TGF-β1
(several hundred fold induction on days 3 and 5) but decreased
fast (within 1 day), suggesting that its message might be highly
unstable. Similarly, Runx2, ALP and osteonectin were signifi-cantly upregulated during osteogenic induction, which is
consistent with their role in osteogenesis (Komori et al., 1997;
Ducy et al., 1997). Interestingly, ALP increased by more than
200-fold during the first week of osteogenic induction and was
further increased to 300-fold during the third week. During
chondrogenic induction, the transcription factor Sox9 exhibited
a two-step upregulation. Within the first 3–4 days it increased
quickly by 50-fold, where it was maintained for 2 weeks before
it increased again to 150-fold within 2 days. Interestingly, the
second induction coincided with increased aggrecan message,
suggesting that a threshold concentration of Sox9 may be
required to promote aggrecan expression, possibly by binding of
Sox9 to the aggrecan promoter (Sekiya et al., 2000). Type X
collagen was also highly expressed during chondrogenic
differentiation. Interestingly, the adipose-specific peroxisome
proliferator-activated receptor gamma (PPARγ), the master
regulator of adipogenic differentiation (Chawla et al., 1994;
Tontonoz et al., 1994), the early marker, lipoprotein lipase
(Ailhaud, 1996) and the late marker, leptin (MacDougald et al.,
1995) were sequentially upregulated during adipogenic
induction of hHF-MSCs. PPARγ was observed immediately and
increased moderately by about 8-fold. Lipoprotein lipase was
observed during the second week and continued to increase
during the third week reaching a very high expression level of
about 50,000-fold. Finally, leptinwas expressed during the third
week of induction and increased 250-fold by day 21. These gene
expression profiles suggested that hHF-MSCs possess a multi-
lineage expression potential similar to other MSCs from bone
marrow or adipose tissue.
Previous studies reported that the differentiation potential
of human MSCs from bone marrow, umbilical cord or adipose
tissue decreasedwith time in culture (Wagner et al., 2008; Kern
et al., 2006; Banfi et al., 2002; Kretlow et al., 2008), prompting
us to determine the differentiation potential of hHF-MSCs as a
function of time in culture and examine whether the differen-
tiation ability of hHF-MSCs varied among the four lineages.
Differentiation to the myogenic lineage was examined by flow
cytometry, immunostaining and hydrogel compaction — a
measure of the SMC force generation ability. Surprisingly,
these experiments revealed a relatively limited decrease in
myogenic differentiation potential even after 11 passages in
















Figure 5 Representative images of tripotent (A), bipotent (B) unipotent (C) clones and clones lacking differentiation capacity
(D). Each clone was stained for Oil Red O, von Kossa and alcian blue. Bars=100 μm (oil Red O); bar=500 μm (Von Kossa and Alcian
Blue).
81Hair follicle derived MSCs are clonally multipotentfraction hHF-MSCs expressing α-SMA – a key smooth muscle cell
marker – increased to more than 80% at P8 and a significant
fraction of cells (~50%) continued to be α-SMA+ even at P11. In
agreement with the biochemical assays, fibrin gel compaction
showed that hHF-MSCs maintained the ability to generate force
and contract hydrogels even at P11, suggesting that hHF-MSCs
may be a good source of functional SMCs for tissue engineering.
The chondrogenic differentiation of hHF-MSCs decreased
gradually over time in culture but a significant fraction of
cells maintained their chondrogenic potential even at P11 as
evidenced by Alcian Blue staining. On the other hand, the
hHF-MSCs osteogenic potential was highest at intermediate
passages (P8) and decreased significantly at P11, as
evidenced by calcium phosphate deposition. Finally, the
adipogenic differentiation ability of hHF-MSCs was most
sensitive to in vitro culture; it decreased rapidly with every
passage and almost diminished by P11. These results are in
agreement with a recent study demonstrating that BM-MSCs
lost their adipogenic ability quickly but maintained their
osteogenic potential even at late passages (Wagner et al.,
2008). Interestingly, loss of adipogenic differentiation
potential was prevented by the adhesion of human BM-
MSCs to denatured type I collagen, suggesting a critical role
of extracellular matrix in the maintenance of stem cellmultipotency (Mauney et al., 2005). It remains to been seen
whether a combination of extracellular matrix and diffusible
signals can also maintain the multipotency of hHF-MSCs,
even after prolonged culture times as required to obtain the
number of cells necessary for cellular therapies.
Notably, clonal analysis of hHF-MSCs demonstrated that
the majority of clones (73%) possessed bi- or tri-lineage
differentiation potential, which was significantly higher
compared to clones derived from dermal fibroblasts (Chen
et al., 2007), suggesting that the hair follicle may be a richer
source of multipotent cells than the dermis. Interestingly,
78% of the bi-potent clones (11 out of 14) displayed both
chondrogenic and osteogenic potential, in agreement with
previous studies reporting that factors promoting (or
decreasing) osteogenic potential promoted (or decreased)
chondrogenic potential as well (Mastrogiacomo et al., 2001).
A recent study reported that cells originating from the
dermal compartment of the follicle are the precursors of the
dermal stem cell and can contribute to dermal maintenance
and wound healing (Biernaskie et al., 2009). Accordingly, it
would be interesting to examine whether hHF-MSCs can
differentiate into the different skin cell types such as
epidermal keratinocytes. In addition, previous studies
showed that skin derived precursors that were isolated
82 V.K. Bajpai et al.from neurospheres in a suspension culture gave rise to both
neural and mesodermal progenitors (Toma et al., 2001),
suggesting that hHF-MSCs might possess similar potential as
well. Collectively, our results suggest that hHF-MSCs are
highly proliferative and clonally multipotent stem cells that
may provide an easily accessible stem cell source for tissue
engineering and regenerative medicine.
Materials and methods
Isolation and cultivation of human hair follicle
mesenchymal stem cells (hHF-MSCs)
Isolation of hHF-MSCs was performed as described previously
(Liu et al., 2010; Liu et al., 2008). Briefly human scalp skin
tissues were obtained from the Cooperative Human Tissue
Network (CHTN, Philadelphia, PA). Small (2 mm×4 mm) pieces
of skin were digested with 0.5% Collagenase Type I (Invitrogen,
Carlsbad, CA) in DMEM (Dulbecco's Modified Eagle Medium,
GIBCO, Grand Island, NY) at 37 °C with occasional agitation for
3–4 h. Single hair follicles were unplugged, washed extensively
and seeded each in a well of a 24-well plate (BD Biosciences,
San Jose, CA) with 500 μL of DMEM supplemented with 10% FBS
(Fetal Bovine Serum; GIBCO). Over the next 7–10 days, cells
migratedout onto the culture plate andproliferated.Onlywells
containing cells originating from the dermal sheath or papilla
(fibroblast-like cells) were used in this study, whereas wells
containing epithelial cells (keratinocytes) were discarded.
Wells containing cells far from the hair follicle were also
discarded to ensure that cells originated from the follicle and
not from remnants of dermal tissue that might have been
carried over accidentally. Expanded cells were cultured in
proliferation media (DMEM supplemented with 10% MSC FBS
(GIBCO) and 1 ng/mL bFGF, (BD Biosciences)) and the medium
was replenished every other day unless otherwise indicated.
For determining the proliferation potential of hHF-MSCs,
3000 cells/cm2 were seeded in triplicates at the indicated
passage number. On the fourth day, cells were counted and
the number of population doublings was calculated assuming
geometric growth. To identify senescent cells in culture, we
performed senescence associated β-Galactosidase (SA-β-
Gal) staining (Cell Signaling, Danvers, MA) according to
manufacturer's instructions and the ratio of total peri-
nuclear blue cells to total number cells was determined in
10 images per passage (each image contains approximately
50 cells).
Adipogenic, chondrogenic, myogenic and
osteogenic differentiation of hHF-MSCs
To determine the differentiation capacity of hHF-MSCs
toward the myogenic, osteogenic, chondrogenic or adipo-
genic lineage, 6×103 cells/cm2 were seeded in tissue culture
plates and cultured in proliferation medium until they
reached confluence. The next day, the proliferation medium
was replaced with the appropriate differentiation medium as
indicated. Thereafter, the differentiation medium was
replenished every 2 days for myogenic lineage and every
3 days for adipogenic, chondrogenic and osteogenic lineage.
For adipogenesis, hHF-MSCs were cultured in DMEM
supplemented with 10% MSC FBS (Invitrogen), 0.5 mM ofisobutyl-methylxanthine (Sigma, St Louis, MO), 1 μM of
dexamethasone (Sigma), 10 μM of insulin (Sigma) and
200 μM of indomethacin (MP Biomedicals, Solon, OH) for
14 days. For chondrogenesis, differentiation was performed
on cell culture dishes as previously described (Asahina et
al., 1993). Briefly, hHF-MSCs were cultured in DMEM
supplemented with 10% MSC FBS, 6.25 μg/mL insulin,
10 ng/mL TGF-β1 (US Biological, Swampscott, MA) and
50 nM of ascorbate-2-phosphate (Sigma) for 21 days. For
myogenic induction, hHF-MSCs were cultured in DMEM
supplemented with 10% MSC FBS and 2 ng/mL TGF-β1(US
biological) for 6 days. For osteogenesis, hHF-MSCs were
cultured in DMEM supplemented with 10% MSC FBS, 0.1 μM
dexamethasone, 50 μM ascorbate-2-phosphate and 10 mM
β-glycerolphosphate (Alfa Aesar, Ward Hill, MA) for 28 days.
Oil Red O staining
After 2 weeks in culture in adipogenic medium cells were
fixed with 10% formalin at room temperature for 60 min and
then incubated with 60% (v/v) isopropanol for 5 min at room
temperature. Then hHF-MSCs were dried and incubated with
0.6% (w/v) filtered Oil Red O in 60% isopropanol/40% water
(Alfa Aesar) at room temperature for 10 min and washed four
times with water to remove any unbound dye. The cells were
imaged using a Zeiss Axio Observer (Zeiss, Thornwood, NY)
inverted microscope and photographed with an ORCA-ER CCD
camera (Hamamatsu, Japan). Quantification of images
containing oil droplets was performed using ImageJ software
(Abramoff et al., 2004).
Alcian Blue staining
After 3 weeks of culture in chondrogenic differentiation
medium, the cells were fixed with 4% para-formaldehyde
(RT; 10 min), stained with 0.5% Alcian Blue (Sigma) in 0.1 N
HCl (PH=1.0) overnight and washed with water. Mosaic
images were taken using a Zeiss Axio Observer inverted
microscope. Alcian Blue stained area was quantified using
ImageJ software.
Von Kossa staining
The degree of osteogenesis of hHF-MSCs was evaluated by Von
Kossa staining (Diagnostic Biosystems, Pleasanton, CA). Briefly,
after 28 days in osteogenic differentiation medium cells were
fixed in 4% paraformaldehyde (RT; 60 min) and incubated with
1% (w/v) silver nitrate solution in dark (RT;30 min). After several
washes cells were exposed to UV light for 60 min followed by
incubation with 5% (w/v) of sodium thiosulfate (RT; 5 min) to
remove any un-reacted silver nitrate. Mosaic imageswere taken
using a Zeiss Axio Observer inverted microscope. Calcium
phosphate deposition area was quantified using ImageJ.
Gel compaction assay
Tocompare the ability of differentiated smoothmuscle cells to
generate force at different passages we performed fibrin gel
compaction assay as described previously (Liu et al., 2008).
Briefly, 1×106 cells were mixed with 800 μL of fibrinogen,
83Hair follicle derived MSCs are clonally multipotentwhich was induced to polymerize with addition of 200 μL
thrombin in a 24-well plate at 37 °C. The concentrations of
fibrinogen and thrombin in the resulting fibrin gel were
2.5 mg/mL and 2.5 U/mL respectively. After one hour
incubation, the gels were released from the surface of the
plate and the initial area of the gel (t=0 h) was captured by an
imaging system (UVP, Upland, CA) andmeasured using ImageJ.
Fibrin gels were cultured in myogenic medium and at the
indicated times the area (A) of each gel was measured and
normalized to the initial area (A0).
Immunocytochemistry
Immunocytochemistry was performed as described
previously (Liu et al., 2008). Briefly, cells were fixed (4%
paraformaldehyde), permeabilized (PBS with 0.1% triton X-
100), blocked (1%BSA/0.01% triton X-100) and incubated
with one of the following antibodies: mouse anti-human
α-SMA (1:50; 4 °C overnight; Serotec, Raleigh, NC), mouse
anti-human calponin (1:50; 4 °C overnight; Dako, Carpin-
teria, CA) or rabbit anti-human myosin heavy chain (1:100;
4 °C overnight; Biomedical Technologies, Stoughton, MA,)
diluted in blocking buffer. Subsequently the cells were
incubated with Alexa Fluor 488 or 594-conjugated goat anti-
mouse (1:100; 1 h at RT; Invitrogen) and counter-stained
with Hoechst nuclear dye (1:400 in PBS; 10 min; Sigma). Cells
that were incubated with only secondary antibody served as
negative controls.
Flow cytometry
Cells expressing α-SMA were measured by flow cytometry as
described previously (Liu et al., 2008). Briefly, on the fourth
day of myogenic differentiation cells were resuspended in 4%
ice cold paraformaldehyde, permeabilizedwithPBS containing
0.1% w/v saponin (MP Biomedical, Inc., Irvine, CA, USA) and
0.05% w/v NaN3 (Fisher Scientific, PA, USA) for 10 min and
blocked with blocking buffer (0.1% w/v saponin, 0.05% w/v
NaN3, 1% BSA in PBS) for 30 min. Cells were then incubated for
1 h with mouse anti-human α-SMA (1:50 in blocking buffer,
Serotec) followed by incubation with Alexa Fluor 488-
conjugated goat anti-mouse secondary antibody (1:100 dilu-
tion, Invitrogen) for 30 min. As a negative control, cells were
incubated with only secondary antibody. After secondary
antibody incubation cells were resuspended in PBS and run in a
FACS Calibur flow cytometer (Becton Dickinson).
RNA isolation and cDNA synthesis
At the indicated times total RNA was isolated using Promega's
RNA isolation kit (Promega Corporation, Madison, WI)
according to the manufacturer's instructions. First strand
cDNA was synthesized from total RNA using superscript III
reverse transcriptase (GIBCO) and oligo dT primer (GIBCO).
Quantitative real time PCR
To determine the kinetics of gene expression during
differentiation, quantitative real time PCR was performed
with the SYBR Green Kit (Bio-Rad, Hercules, CA) according tomanufacturer instructions (see Supplemental Table 1 for
primer sets). The level of each mRNA was quantified using
the ΔCT method and normalized with the expression level of
the housekeeping gene, RPL32. The specificity of each
product was verified by gel electrophoresis.
Clonal differentiation potential of hHF-MSCs
Passage 4 hHF-MSCs were plated using the limiting dilution
method (1 cell/well) in 96-well plates. All wells were examined
daily and those containingmore thanone cellwere discarded for
further analysis. Single cell clones were cultured for 15–20 days
in proliferation medium. Selected clonal populations showing
thehighest proliferation capacitywere further expanded into 48
well plates. Finally, thirty seven clones in total were induced
toward osteogenic, adipogenic or chondrogenic lineage and the
degree of differentiation was assessed by Von Kossa, Oil Red O
and Alcian Blue staining, respectively.
Statistical analysis
Data were expressed as mean±standard deviation and
statistical significance (defined as pb0.05) was determined
using Student's t-test. For the kinetics of gene expression, we
performed one way ANOVA (statistical significance defined
as p≤0.05) followed by post-hoc analysis (Fisher's method
with statistical significance defined as p≤0.05).Supplementary materials related to this article can be
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